Equities

Allmed Solutions Ltd

ALMD:TLV

Allmed Solutions Ltd

Actions
Health CareMedical Equipment and Services
  • Price (ILa)32.50
  • Today's Change-1.30 / -3.85%
  • Shares traded136.72k
  • 1 Year change+4.84%
  • Beta1.1759
Data delayed at least 20 minutes, as of May 23 2024 15:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.

  • Revenue in ILS (TTM)0.00
  • Net income in ILS1.42m
  • Incorporated2004
  • Employees19.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nextgen Biomed Ltd0.00-9.00m8.23m187.00--0.7161-----2.70-2.700.001.420.00-------51.61-32.00-54.98-35.24------------0.1054-------236.16------
Erech Finance Cahalacha Ltd282.00k-25.29m8.43m18.00--1.95--29.89-9.97-9.970.11121.710.0061--0.019---53.84-15.68-132.10-31.24-659.2266.49-8,841.49-133.65---11.040.7966---97.35-50.83-1.01------
Human Xtensions Ltd4.95m-36.64m10.33m50.00--0.3956--2.09-1.37-1.370.1850.97570.09220.46342.2199,000.00-68.25-49.34-77.27-55.6951.6649.34-740.10-485.434.75--0.0608--56.00--17.84---19.95--
Sonovia Ltd0.00-26.76m11.27m44.00--0.3481-----1.66-1.490.001.970.00----0.00-55.93---62.66-------------13.620.0054-------187.75--77.26--
BioLight Life Sciences Ltd118.00k-26.02m19.52m4.00--0.6554--165.39-5.60-5.600.02556.390.0026--0.290329,500.00-60.77-20.22-65.01-21.13-----23,294.07-12,746.09---0.63260.003--87.30-49.76-231.59--92.16--
Elbit Medical Technologies Ltd1.28m-65.40m20.90m232.00--0.788--16.34-0.7287-0.72870.01460.29240.0211--38.67---108.0237.04-110.4338.19-----5,113.2241.14---0.0110.00--314.29-55.19-248.15------
Allmed Solutions Ltd0.001.42m31.90m19.0018.220.672216.81--0.01820.01820.000.49240.00----0.002.431.432.681.59--50.43--15.58----0.0154------111.71---10.48--
Erika B-Cure Laser Ltd29.88m-19.22m33.54m----1.41--1.12-0.185-0.1850.28760.22780.51840.39454.08---33.34---49.63--76.9587.63-64.32-14.480.8936--0.1726---40.62-3.4040.97---19.27--
Endymed Ltd83.72m2.03m39.95m46.0019.190.711710.880.47720.15130.15136.144.081.132.4618.631,819,943.002.7510.383.3813.3251.2051.922.438.913.02--0.0771--6.774.30-34.94-22.83-15.24--
Epitomee Medical Ltd36.75m-20.88m102.99m42.00--0.8052--2.80-0.7054-0.70541.244.300.2095--35.21875,047.60-11.90---12.44-------56.82------0.1021------63.08------
Nissan Medical Industries Ltd.733.91m5.65m131.44m395.0024.480.57482.620.17910.59110.591179.1725.181.025.406.921,858,010.002.644.125.017.7118.5018.762.594.320.63751.830.3585--7.202.20115.67-25.79-3.21--
Data as of May 23 2024. Currency figures normalised to Allmed Solutions Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

1.76%Per cent of shares held by top holders
HolderShares% Held
Ayalon Financial Solutions (2004) Ltd.as of 28 Dec 20231.57m1.61%
Psagot Mutual Funds Ltd.as of 31 Dec 2023115.00k0.12%
Ayalon Mutual Funds Ltd.as of 31 Dec 202332.00k0.03%
Data from 29 Feb 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.